Bonus BioGroup Ltd
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of… Read more
Bonus BioGroup Ltd (BBIXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 2.402x
Based on the latest financial reports, Bonus BioGroup Ltd (BBIXF) has a cash flow conversion efficiency ratio of 2.402x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.02 Million) by net assets ($-1.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bonus BioGroup Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Bonus BioGroup Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bonus BioGroup Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bonus BioGroup Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chesapeake Granite Wash Trust
PINK:CHKR
|
0.036x |
|
KKB Engineering Berhad
KLSE:9466
|
0.044x |
|
Nila Infrastructures Limited
NSE:NILAINFRA
|
-0.083x |
|
Companhia de Tecidos Norte de Minas
SA:CTNM3
|
0.019x |
|
Amines & Plasticizers Limited
NSE:AMNPLST
|
N/A |
|
Binh Dinh Minerals JSC
VN:BMC
|
N/A |
|
Africa Israel Residences Ltd
TA:AFRE
|
-0.035x |
|
Young Bag Micro Motors Co Ltd
KQ:193250
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Bonus BioGroup Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Bonus BioGroup Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.96 Million | $-21.37 Million | -3.072x | -241.08% |
| 2023-12-31 | $29.30 Million | $-26.40 Million | -0.901x | -76.27% |
| 2022-12-31 | $56.39 Million | $-28.82 Million | -0.511x | -8.30% |
| 2021-12-31 | $84.43 Million | $-39.84 Million | -0.472x | +8.05% |
| 2020-12-31 | $30.68 Million | $-15.75 Million | -0.513x | -153.70% |
| 2019-12-31 | $-13.72 Million | $-13.11 Million | 0.956x | -77.39% |
| 2018-12-31 | $-3.18 Million | $-13.43 Million | 4.226x | +128.21% |
| 2017-12-31 | $-6.38 Million | $-11.82 Million | 1.852x | +41.67% |
| 2016-12-31 | $-7.36 Million | $-9.62 Million | 1.307x | -77.50% |
| 2015-12-31 | $-1.39 Million | $-8.07 Million | 5.809x | +144.38% |
| 2014-12-31 | $604.00K | $-7.91 Million | -13.091x | -1005.65% |
| 2013-12-31 | $6.45 Million | $-7.63 Million | -1.184x | -- |